Medical Condition News

RSS

Transcept completes enrollment in TO-2061 Phase 2 trial for obsessive compulsive disorder

Transcept Pharmaceuticals, Inc. today announced that it has completed enrollment in its Phase 2 clinical trial evaluating TO-2061 added as adjunctive therapy for patients with obsessive compulsive disorder (OCD) who have not adequately responded to first-line treatment with an approved OCD medication.

12 Sep 2012

MD Anderson joins API’s Actimab-A Phase I/II trial in acute myeloid leukemia

Actinium Pharmaceuticals, Inc. (API), a biopharmaceutical company that develops innovative targeted payload immunotherapeutics, announced that MD Anderson Cancer Center in Houston, Texas has joined the Company's ongoing Phase I/II trial in newly diagnosed patients with acute myeloid leukemia (AML).

12 Sep 2012

Ageing in neurons follows same rules as in senescing fibroblasts

The ageing process has its roots deep within the cells and molecules that make up our bodies. Experts have previously identified the molecular pathway that react to cell damage and stems the cell's ability to divide, known as cell senescence.

12 Sep 2012

NCDs must be included in new global development goals

In this post in the Guardian's "Poverty Matters" blog, Johanna Ralston, chief executive of the World Heart Federation, and Ann Keeling, chief executive of the International Diabetes Federation, argue non-communicable diseases (NCDs) must be part of any new global development goals, writing, "NCDs and their risk factors worsen poverty, while poverty contributes to rising rates of NCDs, posing a threat to sustainable development."

12 Sep 2012

Annual economic cost of chronic pain is as high as $635 billion: Study

Health economists from Johns Hopkins University writing in The Journal of Pain (www.jpain.org) reported the annual cost of chronic pain is as high as $635 billion a year, which is more than the yearly costs for cancer, heart disease and diabetes.

12 Sep 2012

UB researchers receive NFL grant for sports-related medical research on concussion

After sustaining a concussion, when can an athlete safely return to play? That's the primary question for professional and amateur athletes alike. Now, University at Buffalo sports medicine researchers have been awarded $100,000 from NFL Charities to develop the most objective, scientific method of determining when an athlete who has had a concussion can safely return to play.

12 Sep 2012

Noisy environments cause ears of people with hearing impairments to work differently

The world continues to be a noisy place, and Purdue University researchers have found that all that background chatter causes the ears of those with hearing impairments to work differently.

12 Sep 2012

MHRA approves Sucampo’s AMITIZA to treat chronic idiopathic constipation in the U.K.

Sucampo Pharmaceuticals, Inc. today announced that it has received approval from the Medicines and Healthcare products Regulatory Agency for AMITIZA (lubiprostone) 24 mcg twice daily for the treatment of chronic idiopathic constipation (CIC) and associated symptoms in adults, when response to diet and other non-pharmacological measures (e.g., educational measures, physical activity) are inappropriate.

12 Sep 2012

U.S. to cover costs of cancer monitoring, treatment for 9/11 first responders

The 70,000 surviving firefighters, police officers and other first responders who raced to the World Trade Center after the attacks of September 11, 2001 will be entitled to free monitoring and treatment for some 50 forms of cancer.

12 Sep 2012

Popular Science magazine names University of Minnesota chemist among ‘Brilliant 10’

University of Minnesota chemist Christy Haynes has been named one of Popular Science magazine's "Brilliant 10," an honor that recognizes an elite group of young scientists whose research is expected to dramatically impact their fields. Haynes' profile was published today on the PopSci website and is featured in the Popular Science magazine now on newsstands.

12 Sep 2012

Daily low-dose inhaled corticosteroids do not benefit asthmatics

For two decades, asthma treatment for millions of people with a milder form of the disease has consisted of daily inhaled steroid medicine to reduce inflammation. Now, a new study has found that asthmatics who take the low-dose medication as a daily routine do no better than those who turn to their inhalers only when they have symptoms.

12 Sep 2012

Ethnicity, race affect likelihood of finding suitable unrelated stem cell donors for cancer patients

Researchers at Moffitt Cancer Center and colleagues have published a study describing the greater difficulty in finding matched, unrelated donors for non-Caucasian patients who are candidates for hematopoietic cell transplantation (HCT).

12 Sep 2012

Interventions can help prevent older people from falling

There is now strong evidence that some interventions can prevent falls in people over the age of 65 who are living in their own homes. However, the researchers who reached this conclusion say that care is needed when choosing interventions, as some have no effect. The full details are published this month in The Cochrane Library. This is an update of a previous report that contains data from 51 additional trials, enabling the authors to reach many more conclusions.

12 Sep 2012

Ethypharm, Ampio enter definitive agreement to manufacture Zertane

Ampio Pharmaceuticals, Inc. (AMPE), a clinical stage biopharmaceutical company, with repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, diabetic macular edema (DME) and sexual dysfunction announced today that it has entered into a definitive agreement with Ethypharm Ltd for the manufacturing of Zertane, Ampio's drug for the treatment of premature ejaculation.

12 Sep 2012

Bioengineers design nanoparticles that can safely and predictably infiltrate deep into the brain

The brain is a notoriously difficult organ to treat, but Johns Hopkins researchers report they are one step closer to having a drug-delivery system flexible enough to overcome some key challenges posed by brain cancer and perhaps other maladies affecting that organ.

12 Sep 2012

e-Therapeutics initiates second ETS2101 phase I trial in solid tumours

e-Therapeutics plc announces that it has started a second phase I clinical trial of its anti-cancer drug ETS2101. This trial will enrol up to 45 patients with a variety of solid tumours at two UK centres, St James's University Hospital in Leeds and the Northern Centre for Cancer Care at the Freeman Hospital in Newcastle.

12 Sep 2012

Health ambiguity strongly linked to depression among male stroke survivors

Post-stroke depression is a major issue affecting approximately 33% of stroke survivors. A new study published in the current issue of Archives of Physical Medicine and Rehabilitation reports that the level to which survivors are uncertain about the outcome of their illness is strongly linked to depression. The relationship is more pronounced for men than for women.

12 Sep 2012

APS conference to explore potential mechanisms behind health benefits of exercise

The effects of physical inactivity are, literally, hazardous to your health. Although the detrimental effects of being inactive are generally thought to be associated with childhood obesity and Type 2 diabetes, they have a significant impact on other illnesses. Physical inactivity contributed at least 25 percent to the prevalence of hip fractures, osteoporosis, coronary heart disease, and colon cancer according to recent data released by the U.S. Department of Health and Human Services.

12 Sep 2012

HSS receives NFL grant for research into platelet-rich plasma and stem cells

Researchers at Hospital for Special Surgery have been awarded a $100,000 grant from the National Football League (NFL) Charities to research the use of platelet-rich plasma (PRP) and stem cells as treatments for tendon injury and degeneration. For years, PRP has been used to improve healing in various sports injuries, but there is little evidence of its efficacy.

12 Sep 2012

New model reveals how immune system functions under conditions of neutropenia

Cancer chemotherapy can be a life-saver, but it is fraught with severe side effects, among them an increased risk of infection. Until now, the major criterion for assessing this risk has been the blood cell count: if the number of white blood cells falls below a critical threshold, the risk of infection is thought to be high.

12 Sep 2012

Medical Condition News

Transcept completes enrollment in TO-2061 Phase 2 trial for obsessive compulsive disorder

MD Anderson joins API’s Actimab-A Phase I/II trial in acute myeloid leukemia

Ageing in neurons follows same rules as in senescing fibroblasts

NCDs must be included in new global development goals

Annual economic cost of chronic pain is as high as $635 billion: Study

UB researchers receive NFL grant for sports-related medical research on concussion

Noisy environments cause ears of people with hearing impairments to work differently

MHRA approves Sucampo’s AMITIZA to treat chronic idiopathic constipation in the U.K.

U.S. to cover costs of cancer monitoring, treatment for 9/11 first responders

Popular Science magazine names University of Minnesota chemist among ‘Brilliant 10’

Daily low-dose inhaled corticosteroids do not benefit asthmatics

Ethnicity, race affect likelihood of finding suitable unrelated stem cell donors for cancer patients

Interventions can help prevent older people from falling

Ethypharm, Ampio enter definitive agreement to manufacture Zertane

Bioengineers design nanoparticles that can safely and predictably infiltrate deep into the brain

e-Therapeutics initiates second ETS2101 phase I trial in solid tumours

Health ambiguity strongly linked to depression among male stroke survivors

APS conference to explore potential mechanisms behind health benefits of exercise

HSS receives NFL grant for research into platelet-rich plasma and stem cells

New model reveals how immune system functions under conditions of neutropenia

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News